Moderna, Inc. invites you to their event

Series: High Risk Populations - Protecting Patients at High Risk of Severe COVID-19

About this event

Please join us over the next several weeks for a series of live, virtual events to discuss the continued risks and consequences of COVID-19 infections in high risk populations.

We've assembled a panel of experts to discuss strategies for protecting groups who remain at high risk of severe COVID-19, including:

  • Older adults (65+) - June 7th, 3PM ET
  • Dr Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
  • Dr Stefan Gravenstein, MD, MPH
  • Dr Sten Vermund, MD, PhD
  • Patients with chronic diseases - June 13th, 1PM ET
  • Dr Jeff Goad, PharmD, MPH
  • Dr Joseph Vassalotti, MD
  • Dr Onyema Ogbuagu, MD, FACP, FIDSA
  • Immunocompromised patients - June 15th, 1PM ET
  • Dr Lauren Angelo, PharmD, MBA
  • Dr Mayur Ramesh, MD
  • Dr Ingi Lee, MD, MSCE
  • Dr Jeffrey Lancet, MD
  • Patients with cardiovascular diseases - June 22nd, 1PM ET
  • Dr Jeff Goad, PharmD, MPH
  • Dr Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP
  • Dr Orly Vardeny, PharmD, MS, FAHA, FHFSA
  • Patients with respiratory diseases - June 28th, 1:30PM ET
  • Dr Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
  • Dr Albert Rizzo, MD, FACP, FCCP, FAASM
  • Dr Juanita Mora, MD

Each event will focus on a different high-risk population. You're welcome to attend multiple events, but please register for each date separately.


MED-US-NPSarsCOV2-2300014 5/2023

Moderna, Inc.

Our mission is to deliver the greatest possible impact to people through mRNA medicines.